所有图片(1)
About This Item
线性分子式:
CH3(CH2)17OH
CAS号:
分子量:
270.49
Beilstein:
1362907
EC 号:
MDL编号:
UNSPSC代码:
12352200
推荐产品
蒸汽密度
9.3 (vs air)
蒸汽压
<0.01 mmHg ( 38 °C)
方案
~99%
自燃温度
842 °F
expl. lim.
~8 %
mp
56-59 °C (lit.)
密度
0.812 g/mL at 25 °C (lit.)
SMILES字符串
CCCCCCCCCCCCCCCCCCO
InChI
1S/C18H38O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19/h19H,2-18H2,1H3
InChI key
GLDOVTGHNKAZLK-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
替代产品
产品编号
说明
价格
储存分类代码
11 - Combustible Solids
WGK
nwg
闪点(°F)
383.0 °F - closed cup
闪点(°C)
195 °C - closed cup
个人防护装备
Eyeshields, Gloves, type N95 (US)
法规信息
新产品
Ananya Debnath et al.
The journal of physical chemistry. B, 113(31), 10660-10668 (2009-07-15)
We report molecular dynamics simulations of bilayers using a united atom model with explicit solvent molecules. The bilayer consists of the single tail cationic surfactant behenyl trimethyl ammonium chloride (BTMAC) with stearyl alcohol (SA) as the cosurfactant. We study the
T L Kelson et al.
Journal of inherited metabolic disease, 15(1), 105-111 (1992-01-01)
Sjögren-Larsson syndrome (SLS) is an autosomal recessive disorder associated with reduced activity of the fatty alcohol: NAD+ oxidoreductase complex (FAO). Recent studies indicate that SLS patients are specifically deficient in the fatty aldehyde dehydrogenase (FALDH) component of FAO. To investigate
Jin-Ki Kim et al.
ACS nano, 5(1), 209-216 (2010-12-17)
Nanocarrier systems are frequently characterized by their size distribution, while drug encapsulation in nanocarriers is generally characterized in terms of an entire population, assuming that drug distribution is uniform. Careful characterization of nanocarriers and assessment of their behavior in biological
H O Ammar et al.
International journal of pharmaceutics, 327(1-2), 81-88 (2006-09-05)
Aspirin has become the gold standard to which newer antiplatelet drugs are compared for reducing risks of cardiovascular diseases, while keeping low cost. Oral aspirin has a repertoire of gastrointestinal side effects even at low doses and requires high frequent
Akhtar Siddiqui et al.
International journal of pharmaceutics, 431(1-2), 222-229 (2012-05-09)
The objective of this study was to increase the potency of doxorubicin against adriamycin-resistant NCI/ADR-RES cells by concurrent treatment with doxorubicin and MBO-asGCS loaded solid-lipid nanoparticles (SLN). Loading doxorubicin as ion-pair complex with deoxytaurocholate into cationic and neutral SLN was
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门